Home › Strategic Acquisition Advances Regenerative Medicine
 

Keywords :   


Strategic Acquisition Advances Regenerative Medicine

2013-06-19 06:00:00| Industrial Newsroom - All News for Today

Instron, a leading provider of testing equipment solutions designed to evaluate mechanical properties of materials and components, is pleased to announce the acquisition of Tissue Growth Technologies (TGT), a premier supplier of commercial bioreactors to grow and stimulate developing tissues. <br /> <br /> TGT will become part of the Instron division of ITWs Test and Measurement business. In partnership, we are excited to offer an instrumentation platform that is uniquely designed to cater to ...

Tags: medicine strategic acquisition advances

Category:Industrial Goods and Services

Latest from this category

All news
01.10Boosting Membership Value
Industrial Goods and Services »
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »